Free tool
FAERS Monitor: Geodon
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020825 or its brand name (Geodon, Ziprasidone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
17,662
Serious
12,204
69% of reports
Hospitalization
4,288
Death reported
1,238
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,438
- weight increased1,185
- diabetes mellitus1,004
- anxiety883
- type 2 diabetes mellitus859
- insomnia806
- depression792
- somnolence750
- fatigue727
- tardive dyskinesia707
- tremor699
- nausea682
- dizziness594
- feeling abnormal591
- suicidal ideation577
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 559 |
| 2005 | 664 |
| 2006 | 718 |
| 2007 | 860 |
| 2008 | 438 |
| 2009 | 1,102 |
| 2010 | 2,777 |
| 2011 | 1,613 |
| 2012 | 1,060 |
| 2013 | 734 |
| 2014 | 612 |
| 2015 | 833 |
| 2016 | 867 |
| 2017 | 711 |
| 2018 | 643 |
| 2019 | 660 |
| 2020 | 619 |
| 2021 | 517 |
| 2022 | 474 |
| 2023 | 364 |
| 2024 | 290 |
| 2025 | 304 |
| 2026 | 243 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,497 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| type 2 diabetes mellitusSignal | 859 | 31.2 | 29.2 | 24,442 |
| tardive dyskinesiaSignal | 707 | 30.6 | 28.4 | 19,723 |
| diabetes mellitusSignal | 1,004 | 15.9 | 14.9 | 13,849 |
| suicidal ideationSignal | 577 | 7.5 | 7.0 | 3,264 |
| weight increasedSignal | 1,185 | 6.3 | 6.0 | 5,341 |
| tremorSignal | 699 | 5.0 | 4.7 | 2,263 |
| somnolenceSignal | 750 | 4.4 | 4.1 | 2,013 |
| depressionSignal | 792 | 4.2 | 3.9 | 1,909 |
| anxietySignal | 883 | 3.7 | 3.5 | 1,758 |
| insomniaSignal | 806 | 3.6 | 3.4 | 1,534 |
| feeling abnormalSignal | 591 | 2.9 | 2.7 | 762 |
| dizziness | 594 | 1.4 | 1.3 | 75 |
| drug ineffective | 1,438 | 1.3 | 1.2 | 106 |
| fatigue | 727 | 1.1 | 1.0 | 8 |
| nausea | 682 | 1.0 | 1.0 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.